Ugro Capital
Ugro Capital Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
3 of 4 strong
The short version
AUM expected to remain flat in FY27 with gradual growth in on-balance sheet assets. - Emerging Market LAP and GROx (Embedded Merchant Finance) platforms targeted to grow at approximately 25% CAGR through FY29. - The defocused portfolio (Prime business) anticipated to run down at around 20% annually. - GROx platform demonstrated rapid scaling with 32% quarter-on-quarter AUM growth and 4x portfolio expansion over five quarters. - Monthly loan disbursement in GROx exceeding 60,000 loans, serving about 3.4 lakh active customers. - Emphasis on increasing monthly disbursement volumes to INR 75-80 lakh per branch as branches mature (post-12 months). - Focus on scaling two core businesses (Emerging Market and GROx) while maintaining disciplined asset quality. Management aims to demonstrate value of strategic realignment through consistent performance in coming quarters, focusing on portfolio transition, scaling focused businesses, disciplined asset quality, improving recurring profitability, and cash generation (Page 19).
From Ugro Capital's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- AUM expected to remain flat in FY27 with gradual growth in on-balance sheet assets.
- Emerging Market LAP and GROx (Embedded Merchant Finance) platforms targeted to grow at approximately 25% CAGR through FY29.
- The defocused portfolio (Prime business) anticipated to run down at around 20% annually.
- GROx platform demonstrated rapid scaling with 32% quarter-on-quarter AUM growth and 4x portfolio expansion over five quarters.
- Monthly loan disbursement in GROx exceeding 60,000 loans, serving about 3.4 lakh active customers.
- Emphasis on increasing monthly disbursement volumes to INR 75-80 lakh per branch as branches mature (post-12 months).
2 more points from Ugro Capital's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Ugro Capital said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- UGRO Capital Limited is focused on executing its strategic realignment to create a more focused, recurring, and capital-accretive business.
- Management is raising incremental long-term funding at costs below the average cost of the existing liability book to support growth.
- They are not currently planning to raise equity, aiming to fund growth primarily from profits and disciplined capital management.
- No explicit mention of large current or planned capital expenditure (capex) or strategic investments was made in the call.
- The company is scaling its GROx platform rapidly and expanding its branch network, implying some operational investments in these areas.
2 more points from Ugro Capital's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Finance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Ugro Capital said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Ugro Capital's call on order book
Pro opens every point from 15K+ earnings calls
Continue your research
What Ugro Capital Ltd's management said in earlier quarters
Others in Finance this season
- Regency Fincorp (Q1 FY27)
. Key concall takeaways from Regency Fincorp's Q1 FY27 earnings call — and how it ranks against sector peers.
- Apollo Finvest (Q1 FY27)
The presentation reports **total income of ₹25.9 crore for Q1 FY27**, up from ₹21.6 crore in Q1 FY26, indicating a **year-on-year growth of 20%**. Key investor
- Capital Trust (Q1 FY27)
Total Income for Q1 FY27: ₹12.3 Crores, down 3% YoY from ₹12.6 Crores in Q1 FY26 (Page 31). Key investor presentation takeaways from Capital Trust's Q1 FY27 inv
- CSL Finance (Q1 FY27)
Revenue for Q1FY27 was ₹70.35 crore, up 18% year-on-year (YoY) from ₹59.59 crore in Q1FY26. Key investor presentation takeaways from CSL Finance's Q1 FY27 inves
Arthneeti Pro · Annual
Ugro Capital and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Ugro Capital Q1 FY27 results?
AUM expected to remain flat in FY27 with gradual growth in on-balance sheet assets. - Emerging Market LAP and GROx (Embedded Merchant Finance) platforms targeted to grow at approximately 25% CAGR through FY29. - The defocused portfolio (Prime business) anticipated to run down at around 20% annually. - GROx platform demonstrated rapid scaling with 32% quarter-on-quarter AUM growth and 4x portfolio expansion over five quarters. - Monthly loan disbursement in GROx exceeding 60,000 loans, serving about 3.4 lakh active customers. - Emphasis on increasing monthly disbursement volumes to INR 75-80 lakh per branch as branches mature (post-12 months). - Focus on scaling two core businesses (Emerging Market and GROx) while maintaining disciplined asset quality. Management aims to demonstrate value of strategic realignment through consistent performance in coming quarters, focusing on portfolio transition, scaling focused businesses, disciplined asset quality, improving recurring profitability, and cash generation (Page 19).
What is Ugro Capital share price analysis?
Ugro Capital currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 9.8 with a market cap of ₹1,378 Cr. Investors should review the full earnings analysis for detailed insights.
Is Ugro Capital planning capital expenditure?
UGRO Capital Limited is focused on executing its strategic realignment to create a more focused, recurring, and capital-accretive business.
Keep Ugro Capital on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.